WAM
AMAG

Wealthspire Advisors (Maryland)’s AMAG Pharmaceuticals AMAG Stock Holding History

Wealthspire Advisors (Maryland)’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-79
Closed -$1K – 2383
2019
Q1 		$1K Sell
79
-285
-78% -$4.24K ﹤0.01% 2441
2018
Q4 		$6K Buy
364
+23
+7% +$438 ﹤0.01% 1696
2018
Q3 		$7K Buy
341
+17
+5% +$387 ﹤0.01% 1696
2018
Q2 		$6K Buy
324
+16
+5% +$354 ﹤0.01% 1754
2018
Q1 		$6K Buy
308
+250
+431% +$4.23K ﹤0.01% 1780
2017
Q4 		$1K Buy
+58
New +$875 ﹤0.01% 2388

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

Wealthspire Advisors (Maryland)'s AMAG Position: Q2 2019 in Review

Wealthspire Advisors (Maryland) sold out of AMAG Pharmaceuticals (AMAG) in Q2 2019, closing a stake of 79 shares — an estimated $1K sold.

Wealthspire Advisors (Maryland) first reported a position in AMAG in Q4 2017 and held it in 6 quarters. The position peaked at $7K in Q3 2018. 170 funds tracked by Wall St. Rank hold AMAG as of Q2 2019.

  • Wealthspire Advisors (Maryland) reported no remaining AMAG Pharmaceuticals position as of Q2 2019 after selling out during the quarter.
  • Wealthspire Advisors (Maryland) sold 79 AMAG Pharmaceuticals shares in Q2 2019, an estimated $1K.
  • Wealthspire Advisors (Maryland) first reported a position in AMAG Pharmaceuticals in Q4 2017 and held it in 6 quarters.
  • Wealthspire Advisors (Maryland)'s AMAG Pharmaceuticals position peaked at $7K in Q3 2018.
  • 170 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2019.

Based on Wealthspire Advisors (Maryland)'s 13F filing for Q2 2019, filed 12 Aug 2019.